CEL SCI Corp Stock Pattern Recognition Matching Low

CVM Stock  USD 3.74  0.04  1.08%   
The pattern recognition view organizes Matching Low recognition and supporting indicators around CEL SCI. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was six with a total number of output elements of fifty-five. The function did not return any valid pattern recognition events for the selected time horizon. The Matching Low pattern shows low bullish reversal trend for CEL SCI Corp.

CEL SCI Technical Analysis Modules

Most technical analysis of CEL SCI help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CEL from various momentum indicators to cycle indicators. When you analyze CEL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About CEL-SCI Corp

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange. This overview emphasizes how CEL SCI compares to peers on valuation quality and operating consistency. Current metrics include P/B of 2.94. CEL SCI has market cap of 31.29 M, ROE of -2.12%.

Methodology

Unless otherwise specified, financial data for CEL SCI Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CEL (USA Stocks:CVM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

CEL SCI Corp is covered by 1 analyst. Representative analyst firms may include Stifel, Barclays, Morgan Stanley, Wells Fargo Securities, Evercore ISI, among others. Updates may occur throughout the day.


Become your own money manager

Tracking CEL SCI inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Advertising Idea
Advertising
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested over 200 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares

More Resources for CEL Stock Analysis

A structured review of CEL SCI Corp often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame CEL SCI Corp Stock are listed below:
CEL SCI has market cap of 31.29 M, ROE of -2.12%. Trending Equities can help frame allocation decisions. The allocation includes a position in CEL SCI Corp in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Analysis related to CEL SCI should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
 Earnings Share
-3.70
 Revenue Per Share
0.001
 Quarterly Revenue Growth
-0.63
 Return On Assets
-0.60
 Return On Equity
-2.12
Investors evaluate CEL SCI Corp using market value and book value, each describing different facets of the business. CEL SCI's market capitalization is 31.29 M. A P/B ratio of 2.94 indicates the market values CEL SCI above its accounting book value. Enterprise value stands at 35.56 M. Intrinsic value is an analytical estimate of CEL SCI's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Value and price for CEL SCI are related but not identical, and they can diverge across cycles. For CEL SCI, key inputs include a P/B ratio of 2.94, and ROE of -2.12%. Trading price represents the transaction level agreed by market participants.